Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)

TORONTO, July 24– Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce call-in numbers and webcast link for the Annual General and Special Meeting of the shareholders of Blueberries Medical Corp. (the “AGM”).   The AGM will be held on Friday,Continue reading “Blueberries Announces Call-in and Webcast Details for its Annual General and Special Meeting (“AGM”)”

Blueberries Announces Strategic Partnership with medcann

Production of THC Medicinal Extracts to Start in Q4, 2020 Blueberries will develop a Research and Development (“R&D”) project with medcann to produce commercial THC dominant extracts. The Company will utilize its extraction capabilities to process the THC dominant cannabis flower cultivated by medcann. In 2018, medcann became the first and only company to obtainContinue reading “Blueberries Announces Strategic Partnership with medcann”

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agriculture (“ICA”). Blueberries hasContinue reading “Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners”